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Abstract
A 17-year-old female with Chiari 2 malformation developed cerebral infarction with angiographically
typical bilateral moyamoya vessels manifesting as sudden onset of moderate left hemiparesis. Magnetic
resonance imaging revealed multiple infarcts in the right frontal lobe, agenesis of the corpus callosum,
upward herniation of the dorsal cerebellum, tectal beak of the midbrain, and downward herniation of
the cerebellar vermis. Cerebral angiography demonstrated occlusion of the bilateral internal carotid ar-
teries and basal moyamoya vessels. Single photon emission computed tomography showed significantly
reduced regional cerebral blood flow in the right frontoparietal cortex. The cerebral vascular reactivity
to acetazolamide was diminished in both cerebral hemispheres. She underwent superficial temporal ar-
tery-middle cerebral artery anastomosis combined with encephalo-myo-synangiosis on the right, and on
the left 6 months later. Cerebral angiography performed 4 months after the second operation showed
good patency of the bypasses and substantial collateral vessels in both cerebral hemispheres. This as-
sociation may have happened by chance, and a common etiology is uncertain, but a currently undeter-
mined genomic component might have contributed to the disease progression.
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Introduction
Moyamoya disease is characterized by progressive
narrowing of the bilateral internal carotid arteries
followed by development of basal collateral vessels,
and is one of the discrete causes of ischemic
stroke.10,14) Moyamoya syndrome may include in-
herited disorders such as Down syndrome,S) neu-
rofibromatosis 1,9) and protein C deficiency,?) as well
as other acquired pathological conditions which
may be involved in the mechanisms causing such
moyamoya phenomena.1-3) Autoimmune mecha-
nisms such as Grave's disease,3) Behcet's disease,6)
and antiphospholipid syndrorne1) may also be in-
volved in the development of moyamoya syndrome,
although cross-reactivity of autoantibodies to
cerebral vessels has not yet been clearly demonstrat-
ed. Genetic factors may also contribute as the possi-




ble locations of genes for familial moyamoya disease
have been demonstrated.4,lO,14) However, only a few
congenital diseases associated with moyamoya syn-
drome, such as neurofibromatosis 1,14) Fanconi ane-
mia,2) and Marfan syndrome,2) are known to have
genetic locations close to the ones for familial
moyamoya disease. In addition, clear pathogenetic
links remain to be identified. Therefore, most con-
genital disorders, including Down syndrome,5) the
most frequently reported disorder, may be only asso-
ciated with moyamoya syndrome.
Here we describe a unique case of moyamoya syn-
drome associated with Chiari 2 malformation, a con-
genital central nervous system (eNS) anomaly com-
plex.12,13)
Case Report
A 17-year-old female suddenly developed moderate
left hemiparesis, and was admitted to our hospital.
She was found at birth to have Chiari 2 malforma-
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Fig. 1 A: Diffusion-weighted magnetic resonance
(MR) image showing multiple infarcts in the
right frontal lobe and image distortion
around the right ventricular catheter. B:
Fluid-attenuated inversion recovery MR im-
age showing agenesis of the corpus callo-
sum. C: Sagittal T2-weighted MR image
demonstrating upward herniation of the
dorsal cerebellum, tectal beak of the mid-
brain, elongation of the fourth ventricle,
and downward herniation of the cerebellar
vermis.
tion including lumbar myelomeningocele and
hydrocephalus. She underwent closure of the lum-
bar myelomeningocele, ventriculoperitoneal shunt
placement, and foramen magnum decompression.
She went to school with urinary incontinence, thus
requiring self-removal of urine. She had not under-
gone magnetic resonance (MR) imaging or other
type of vascular imaging of the brain until the
present ischemic episode. Her family history did not
include any cases of cerebrovascular diseases, neu-
rodegenerative diseases, or autoimmune diseases.
On admission, diffusion-weighted MR imaging
revealed multiple infarcts in the right frontal lobe
(Fig. lA). Fluid-attenuated inversion recovery MR
imaging demonstrated agenesis of the corpus callo-
sum (Fig. lB). Sagittal T2-weighted MR imaging
showed upward herniation of the dorsal cerebellum,
tectal beak of the midbrain, and downward hernia-
tion of the cerebellar vermis (Fig. lC). Cerebral an-
giography demonstrated occlusion of the bilateral
internal carotid arteries and basal moyamoya ves-
sels, consistent with primary moyamoya disease
(Fig. 2). Single photon emission computed tomogra-
phy using N-isopropyl-4 iodoamphetamine showed
significantly reduced regional cerebral blood flow in
the right frontoparietal cortex. The cerebral vascular
reactivity to acetazolamide was diminished in both
cerebral hemispheres. Laboratory examinations in-
cluding endocrinological, autoimmune, and pro-
thrombotic studies were normal.
Following administration of aspirin for 3 weeks,
the patient underwent superficial temporal artery-
Fig. 2 Right (A, B) and left (C, D) internal carotid
angiograms, anteroposterior (A, C) and
lateral views (B, D), revealing occlusion of
the bilateral internal carotid arteries, typi-
cal moyamoya collateral vessels, and trans-
dural anastomoses, more advanced in the
right hemisphere (stage 4) than in the left
(stage 3).
middle cerebral artery anastomosis combined with
encephalo-myo-synangiosis on the right. Her
postoperative course was uneventful, and she was
able to walk. She has not experienced any further
ischemic episodes, and underwent the same surgery
on the left 6 months after the first operation.
Cerebral angiography performed 4 months after the
second operation showed good patency of the
bypasses and substantial collateral vessels in both
cerebral hemispheres.
Discussion
Chiari 2 malformation is defined as a CNS anomaly
complex including hindbrain herniation, my-
elodysplasia, hydrocephalus, and other craniover-
tebral disorders. 12,13) A molecular genetic cause of
pathogenesis has been proposed,ll) but cerebrovas-
cular involvement is rarely reported. 12) The concen-
tration of basic fibroblast growth factor, one of the
possible mediators of angiogenesis, is increased in
the cerebrospinal fluid of patients with moyamoya
disease and other congenital CNS disorders such as
Chiari 1 malformation and tethered spinal cord,8)
but little is known about any possible common etiol-
ogy between these conditions.
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The present case of moyamoya syndrome associ-
ated with Chiari 2 malformation had a clinical
manifestation and angiographic findings similar to
cases of primary moyamoya disease. The patient had
no exclusive history, and the involvement of pro-
thrombotic disorders or autoimmune mechanisms
seems unlikely. This combination may have oc-
curred by chance, but the involvement of some cur-
rently undetermined genomic component may have
been involved in the disease progression. The clini-
cal course of moyamoya syndrome depends on the
associated disorders, so understanding of the under-
lying mechanisms is important.
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